NCT06064227 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bhandari P, Kim M
Predictors of the Health-Promoting Behaviors of Nepalese Migrant Workers. J Nurs Res. 2016 Sep;24(3):232-9. doi: 10.1097/jnr.0000000000000120.
Dassel KB, Carr DC
Does Dementia Caregiving Accelerate Frailty? Findings From the Health and Retirement Study. Gerontologist. 2016 Jun;56(3):444-50. doi: 10.1093/geront/gnu078. Epub 2014 Aug 26.
Farrance C, Tsofliou F, Clark C
Adherence to community based group exercise interventions for older people: A mixed-methods systematic review. Prev Med. 2016 Jun;87:155-166. doi: 10.1016/j.ypmed.2016.02.037. Epub 2016 Feb 24.
Gill TM, Gahbauer EA, Allore HG, Han L
Transitions between frailty states among community-living older persons. Arch Intern Med. 2006 Feb 27;166(4):418-23. doi: 10.1001/archinte.166.4.418.
Hepburn M
The Variables Associated With Health Promotion Behaviors Among Urban Black Women. J Nurs Scholarsh. 2018 Jul;50(4):353-366. doi: 10.1111/jnu.12387. Epub 2018 Apr 24.
Kwak D, Thompson LV
Frailty: Past, present, and future? Sports Med Health Sci. 2020 Nov 30;3(1):1-10. doi: 10.1016/j.smhs.2020.11.005. eCollection 2021 Mar.
Mendis, Shanthi, et al
Global atlas on cardiovascular disease prevention and control. World Health Organization, 2011.
Pender, N
J.; Murdaugh, C.L.; Parsons, M. Health Promotion in Nursing Practice, 6th ed.; Pearso: Boston, MA, USA, 2011; pp. 122-126.
Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J
Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009 Jun;64(6):675-81. doi: 10.1093/gerona/glp012. Epub 2009 Mar 10.
Xue QL
The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011 Feb;27(1):1-15. doi: 10.1016/j.cger.2010.08.009.

The Effect of Health Promotion Comprehensive Education Intervention on the Frailty Levels of Elderly Family Caregivers

Details for clinical trial NCT06064227

Clinical trial NCT06064227 - References